Walgreens Boots Alliance (NASDAQ:WBA) Issues Earnings Results, Beats Expectations By $0.13 EPS

Walgreens Boots Alliance (NASDAQ:WBA) issued its earnings results on Friday. The pharmacy operator reported $0.51 EPS for the quarter, topping the consensus estimate of $0.38 by $0.13, RTT News reports. Walgreens Boots Alliance had a positive return on equity of 14.23% and a negative net margin of 5.85%. The business had revenue of $39.50 billion during the quarter, compared to the consensus estimate of $37.40 billion. During the same quarter last year, the company earned $0.66 EPS. The firm’s revenue was up 7.6% compared to the same quarter last year. Walgreens Boots Alliance updated its FY 2025 guidance to 1.400-1.800 EPS and its FY25 guidance to $1.40-$1.80 EPS.

Walgreens Boots Alliance Price Performance

Shares of Walgreens Boots Alliance stock opened at $9.22 on Friday. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.68 and a quick ratio of 0.37. Walgreens Boots Alliance has a one year low of $8.08 and a one year high of $25.63. The business’s 50 day simple moving average is $9.21 and its two-hundred day simple moving average is $9.92. The stock has a market capitalization of $7.96 billion, a P/E ratio of -0.92, a price-to-earnings-growth ratio of 1.36 and a beta of 0.64.

Walgreens Boots Alliance Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Thursday, December 12th. Investors of record on Monday, November 18th were issued a dividend of $0.25 per share. This represents a $1.00 annualized dividend and a yield of 10.85%. The ex-dividend date of this dividend was Monday, November 18th. Walgreens Boots Alliance’s dividend payout ratio is presently -9.99%.

Wall Street Analysts Forecast Growth

A number of research analysts have recently commented on WBA shares. Jefferies Financial Group reduced their price target on shares of Walgreens Boots Alliance from $19.00 to $9.00 and set a “hold” rating for the company in a research report on Wednesday, October 23rd. Barclays upped their target price on Walgreens Boots Alliance from $7.00 to $8.00 and gave the stock an “underweight” rating in a research note on Wednesday, October 16th. Morgan Stanley dropped their price target on Walgreens Boots Alliance from $9.00 to $7.00 and set an “underweight” rating for the company in a research report on Friday, October 11th. Royal Bank of Canada decreased their price objective on shares of Walgreens Boots Alliance from $13.00 to $9.00 and set a “sector perform” rating on the stock in a research report on Wednesday, December 4th. Finally, Truist Financial dropped their target price on shares of Walgreens Boots Alliance from $13.00 to $10.00 and set a “hold” rating for the company in a research report on Monday, October 7th. Four analysts have rated the stock with a sell rating, nine have issued a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat.com, Walgreens Boots Alliance has a consensus rating of “Hold” and a consensus target price of $12.58.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.